Correlation Between Kronos Bio and Recursion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Kronos Bio and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kronos Bio and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kronos Bio and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Kronos Bio and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kronos Bio with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kronos Bio and Recursion Pharmaceuticals.
Diversification Opportunities for Kronos Bio and Recursion Pharmaceuticals
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Kronos and Recursion is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Kronos Bio and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Kronos Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kronos Bio are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Kronos Bio i.e., Kronos Bio and Recursion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Kronos Bio and Recursion Pharmaceuticals
Given the investment horizon of 90 days Kronos Bio is expected to generate 0.53 times more return on investment than Recursion Pharmaceuticals. However, Kronos Bio is 1.87 times less risky than Recursion Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest 97.00 in Kronos Bio on November 6, 2024 and sell it today you would earn a total of 4.00 from holding Kronos Bio or generate 4.12% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kronos Bio vs. Recursion Pharmaceuticals
Performance |
| Timeline |
| Kronos Bio |
| Recursion Pharmaceuticals |
Kronos Bio and Recursion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kronos Bio and Recursion Pharmaceuticals
The main advantage of trading using opposite Kronos Bio and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kronos Bio position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.| Kronos Bio vs. Cyclerion Therapeutics | Kronos Bio vs. Larimar Therapeutics | Kronos Bio vs. Addex Therapeutics | Kronos Bio vs. Achilles Therapeutics PLC |
| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |